SOSV

New Culture and CJ CheilJedang Enter into Strategic Partnership for Commercial Manufacturing Capacity

Retrieved on: 
星期二, 五月 14, 2024

SAN LEANDRO, Calif., May 14, 2024 /PRNewswire/ -- New Culture, the pioneering animal-free dairy company, announced today a strategic partnership with CJ CheilJedang, the world's largest supplier of bioproducts made from microbial fermentation. The partnership is focused on driving down the cost of New Culture's animal-free casein protein, unlocking commodity pricing including for New Culture's first product, mozzarella for pizzerias.

Key Points: 
  • SAN LEANDRO, Calif., May 14, 2024 /PRNewswire/ -- New Culture, the pioneering animal-free dairy company, announced today a strategic partnership with CJ CheilJedang, the world's largest supplier of bioproducts made from microbial fermentation.
  • "Our partnership with CJ CheilJedang facilitates access to some of the largest and most sophisticated fermentation facilities on the planet to truly transform the dairy industry."
  • "Whether through commercial manufacturing, procurement, or other technical support, this partnership enables the full scope of our expertise to accelerate New Culture's growth and market leadership."
  • This partnership with CJ CheilJedang further strengthens New Culture's manufacturing position and path to profitability, building on the company's previously announced partnership with ADM, the US-based, alternative protein and fermentation leader.

Allozymes Raises $15 Million in Series A Funding, Poised to Revolutionize Industries with Enzymatic Solutions

Retrieved on: 
星期二, 五月 14, 2024

Additionally, the funding will fuel the development of the industry's most comprehensive enzyme data library for future enzyme discovery endeavors.

Key Points: 
  • Additionally, the funding will fuel the development of the industry's most comprehensive enzyme data library for future enzyme discovery endeavors.
  • Powerful AI/ML algorithms will leverage this data to enable the prediction and generation of novel, robust biocatalytic solutions for various industries.
  • Akbar Vahidi, CTO of Allozymes, added: "Our platform represents a significant step forward in democratizing access to powerful enzymatic solutions.
  • With this strategic investment and a dedicated team, Allozymes is poised to become a global leader in enzyme innovation.

Allozymes Raises $15 Million in Series A Funding, Poised to Revolutionize Industries with Enzymatic Solutions

Retrieved on: 
星期二, 五月 14, 2024

Additionally, the funding will fuel the development of the industry's most comprehensive enzyme data library for future enzyme discovery endeavors.

Key Points: 
  • Additionally, the funding will fuel the development of the industry's most comprehensive enzyme data library for future enzyme discovery endeavors.
  • Powerful AI/ML algorithms will leverage this data to enable the prediction and generation of novel, robust biocatalytic solutions for various industries.
  • Akbar Vahidi, CTO of Allozymes, added: "Our platform represents a significant step forward in democratizing access to powerful enzymatic solutions.
  • With this strategic investment and a dedicated team, Allozymes is poised to become a global leader in enzyme innovation.

SOSV's HAX Opens 35,000-SF Global Headquarters in Newark, N.J., to Grow Hard Tech Startups

Retrieved on: 
星期三, 五月 1, 2024

NEWARK N.J., April 30, 2024 /PRNewswire-PRWeb/ -- Today, the City of Newark announced that SOSV's hard tech startup program HAX has officially opened its 35,000-square-foot global headquarters in Newark. A startup development program run by global venture capital firm SOSV, HAX provides hard tech startups across climate, industrial automation, and health with funding, work and lab space, hands-on engineering and operations support.

Key Points: 
  • Hard tech startup program chose Newark after a worldwide search; plans to invest $25M in 100 companies by 2027
    NEWARK N.J., April 30, 2024 /PRNewswire-PRWeb/ -- Today, the City of Newark announced that SOSV's hard tech startup program HAX has officially opened its 35,000-square-foot global headquarters in Newark.
  • A startup development program run by global venture capital firm SOSV , HAX provides hard tech startups across climate, industrial automation, and health with funding, work and lab space, hands-on engineering and operations support.
  • With the opening of HAX, Newark accelerates its momentum as an emergent global hub for manufacturing and technological breakthroughs.
  • "We are proud to stand alongside HAX and key stakeholders to commemorate the company's official expansion into the city of Newark."

India Social Commerce Market Intelligence Report 2024: Global Platforms are Shutting Operations in India Amid Growing Competition in the Sector - ResearchAndMarkets.com

Retrieved on: 
星期二, 二月 13, 2024

This report provides a detailed data centric analysis of the social commerce industry, covering market opportunities and risks.

Key Points: 
  • This report provides a detailed data centric analysis of the social commerce industry, covering market opportunities and risks.
  • With over 50+ KPIs at country level, this report provides a comprehensive understanding of social commerce market dynamics, market size and forecast, and market share statistics.
  • To tap into the growing sector, social commerce platforms are expected to increase their marketing spending over the medium term.
  • In-depth Understanding of Social Commerce Market Dynamics: Understand market opportunities and key trends along with forecast (2020-2029).

Feel Therapeutics Brings Michel Vounatsos as Chairman Of The Advisory Board, and Secures New Funding to Advance Digital Precision Medicine for Mental Health

Retrieved on: 
星期二, 一月 9, 2024

SAN FRANCISCO, Jan. 9, 2024 /PRNewswire-PRWeb/ -- Feel Therapeutics, the Digital Precision Medicine company for mental and behavioral health, announced today that Michel Vounatsos, former CEO of Biogen, has joined as a Chairman of their Advisory Board. Additionally, Feel has secured new funding from Satori Neuro, Metavallon VC, and existing investors such as SOSV, SeedtoB, and others, to fuel its expansion plans. Along with the new funding, Amy Kruse, Chief Investment Officer of Satori Neuro, a pioneering fund focused on mental health, neurotechnology, and human flourishing, has joined the Board of Directors as an observer. These new investors join Feel's existing group of investors, which includes Felicis, SOSV, Anthemis, SeedtoB, and others, that continue to support the company.

Key Points: 
  • SAN FRANCISCO, Jan. 9, 2024 /PRNewswire-PRWeb/ -- Feel Therapeutics , the Digital Precision Medicine company for mental and behavioral health, announced today that Michel Vounatsos, former CEO of Biogen, has joined as a Chairman of their Advisory Board.
  • Feel Therapeutics welcomes Michel Vounatsos, former Biogen CEO, as Advisory Board Chairman.
  • "I am excited to join Feel Therapeutics at this pivotal moment in their journey," said Michel Vounatsos.
  • Feel's approach to precision medicine in mental & behavioral health can transform how we manage, monitor, and treat those conditions.

Lingrove Secures $10 Million in Financing to Ramp up Production of ekoa® - Plant-based Surfaces and Panels for Climate-friendly, Healthy Interiors

Retrieved on: 
星期一, 十二月 18, 2023

The funding enables Lingrove to ramp up production of ekoa®, a natural, durable, and carbon-negative alternative to conventional materials used in construction.

Key Points: 
  • The funding enables Lingrove to ramp up production of ekoa®, a natural, durable, and carbon-negative alternative to conventional materials used in construction.
  • Lingrove aims to reinvent and decarbonize the trillion-dollar renovation and new construction materials market, making interiors healthy, beautiful, and climate-friendly.
  • Lingrove, which launched inhouse manufacturing of ekoa® surfaces in late 2023, has secured millions in ekoa® pre-orders.
  • Despite a challenging fundraising environment, Lingrove successfully secured strategic financing to foster a better future through fast-growing plants, starting with healthy and beautiful interiors.

Monozukuri Ventures Launches "Deep Tech Forum" and Brings It to Three North American Cities in January 2024 and Japan in March 2024

Retrieved on: 
星期一, 十一月 20, 2023

KYOTO, Japan and NEW YORK, Nov. 20, 2023 /PRNewswire-PRWeb/ -- Monozukuri Ventures, a venture capital firm focused on hardware and deep tech startups, today announced the launch of the Deep Tech Forum, where the world's leading deep tech startup ecosystem of founders, startups, investors and supporting communities will come together to address the barriers to growth and success.

Key Points: 
  • "Accelerators and VC support alone are not enough for deep tech startups.
  • The Deep Tech Forum in Kyoto is scheduled to be held on March 7th and 8th, 2024.
  • "Accelerators and VC support alone are not enough for deep tech startups, especially those spun out of universities.
  • The BDC Deep Tech Venture Fund is Canada's largest VC fund ($200 million) dedicated to deep tech.

Cromatic Closes $5.3 Million in Oversubscribed Seed Round to Modernize Life Science R&D Outsourcing

Retrieved on: 
星期四, 十一月 9, 2023

Cromatic , a full-stack digital platform for outsourced life sciences research, today announced it has closed $5.3 million in funding.

Key Points: 
  • Cromatic , a full-stack digital platform for outsourced life sciences research, today announced it has closed $5.3 million in funding.
  • LifeX Ventures and AgFunder led the round with participation from Work Life Ventures, Not Boring Capital, FJ Labs, What If Ventures, Lux Capital, and angel investors.
  • The demand for biotech and pharmaceutical R&D outsourcing is growing rapidly and is expected to be worth $275 billion by 2030.
  • Cromatic is harnessing this newfound capacity in a coherent platform for a new generation of nimble and capital-efficient biotech companies.

Backbar rebrands to Sidework as it raises new capital, bringing total raised over $10 million

Retrieved on: 
星期三, 十月 25, 2023

SAN DIEGO, Oct. 25, 2023 /PRNewswire-PRWeb/ -- Sidework, a pioneering beverage technology company formerly known as Backbar, has closed new funding to bring their total raised to over $10 million. A testament to the industry's confidence in its game-changing technology, the new money is led by Cherubic Ventures with continuing participation from Finistere Ventures, SOSV, Outlander Labs, and Pathbreaker Ventures. Matt Cheng, Cherubic Ventures' general partner, said the following: "We believe in Sidework's vision to revolutionize the beverage industry. This funding marks an exciting milestone, reflecting the pivotal role they are playing to reshape how beverages are crafted and served." The rebrand signifies Sidework's broadened scope, where customers can dispense drinks, manage inventory, and buy ingredients through Sidework's hardware, software, and marketplace ecosystem.

Key Points: 
  • Matt Cheng, Cherubic Ventures' general partner, said the following: "We believe in Sidework's vision to revolutionize the beverage industry.
  • This funding marks an exciting milestone, reflecting the pivotal role they are playing to reshape how beverages are crafted and served."
  • The rebrand signifies Sidework's broadened scope, where customers can dispense drinks, manage inventory, and buy ingredients through Sidework's hardware, software, and marketplace ecosystem.
  • Sidework's ecosystem addresses two fundamental challenges: Not enough venues serve great tasting, modern drinks and those drinks are extremely difficult to make.